Total Payments
$1,339
2024 Payments
$261.87
Companies
12
Transactions
74
Payment Breakdown by Category
Food & Beverage$1,339 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,339 | 74 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $411.64 | 14 | $0 (2024) |
| ABBVIE INC. | $300.91 | 19 | $0 (2024) |
| Lilly USA, LLC | $255.17 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $106.43 | 7 | $0 (2023) |
| GlaxoSmithKline, LLC. | $103.38 | 7 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $58.83 | 4 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $26.23 | 2 | $0 (2023) |
| Ultragenyx Pharmaceutical Inc. | $21.97 | 1 | $0 (2022) |
| Xeris Pharmaceuticals, Inc. | $14.73 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $14.17 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $261.87 | 16 | ABBVIE INC. ($151.25) |
| 2023 | $367.36 | 24 | Lilly USA, LLC ($86.94) |
| 2022 | $467.58 | 23 | Novo Nordisk Inc ($173.57) |
| 2021 | $242.66 | 11 | Novo Nordisk Inc ($131.61) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE, AVYCAZ | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus, Tresiba | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | ABBVIE INC. | AVYCAZ (Drug), DALVANCE | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/05/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE, AVYCAZ | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.91 | General |
| 06/04/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | Novo Nordisk Inc | Tresiba (Drug), Rybelsus, Ozempic | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Diabetes | ||||||
| 04/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Diabetes | ||||||
| 03/07/2024 | Novo Nordisk Inc | Tresiba (Drug), Rybelsus, Ozempic | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Diabetes | ||||||
| 02/29/2024 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/01/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/09/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Diabetes | ||||||
| 12/06/2023 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 12/06/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Diabetes | ||||||
| 12/06/2023 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/07/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/02/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.59 | General |
| 10/30/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Diabetes | ||||||
| 10/05/2023 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/25/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Diabetes | ||||||
About Kristen Smith
Kristen Smith is a Family healthcare provider based in Indianola, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2017. The National Provider Identifier (NPI) number assigned to this provider is 1154842409.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kristen Smith has received a total of $1,339 in payments from pharmaceutical and medical device companies, with $261.87 received in 2024. These payments were reported across 74 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,339).
Ad
Practice Information
- Specialty Family
- Location Indianola, MS
- Active Since 06/27/2017
- Last Updated 06/27/2017
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1154842409
Products in Payments
- MOUNJARO (Drug) $213.38
- TEFLARO (Drug) $147.30
- Rybelsus (Drug) $134.93
- RYBELSUS (Drug) $125.00
- ENTRESTO (Drug) $106.43
- DALVANCE (Drug) $89.77
- Tresiba (Drug) $80.25
- TRELEGY ELLIPTA (Drug) $60.89
- Ozempic (Drug) $54.11
- AREXVY (Drug) $42.49
- AVYCAZ (Drug) $34.42
- VRAYLAR (Drug) $29.42
- Kerendia (Drug) $26.23
- TRULICITY (Drug) $24.59
- Crysvita (Drug) $21.97
- Saxenda (Drug) $17.35
- KEVEYIS (Drug) $14.73
- FARXIGA (Drug) $14.17
- Yupelri (Drug) $14.10
- JARDIANCE (Drug) $12.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Indianola
Mr. Bobby Paxton, Cfnp, CFNP
Family — Payments: $1,799
Family $1,799
Mary Mcneer, Cfnp, CFNP
Family — Payments: $1,304
Family $1,304
Holly Labertew, Arnp, ARNP
Family — Payments: $470.12
Family $470.12
Elizabeth Dawson, Cfnp, CFNP
Family — Payments: $464.69
Family $464.69
Terrie Rowland, Cfnp, CFNP
Family — Payments: $104.36
Family $104.36
Patricia Smith, Arnp, Fnp-C, ARNP, FNP-C
Family — Payments: $94.37
Family $94.37